ethnic composition and outcomes of covid-19 patients, 28 ......on the basis of the british national...

12
Ethnic Composition and Outcomes of COVID-19 Patients Ahmed M. Alaa 1 , Zhaozhi Qian 2 , Jem Rashbass 3 , Keith Gomes Pinto 3 , Jonathan Benger 3 , and Mihaela van der Schaar 2 1 University of California, Los Angeles, CA 90095, USA 2 University of Cambridge Centre for Mathematical Sciences, Wilberforce Rd, Cambridge CB3 0WA, UK 3 NHS Digital The rate of SARS-CoV-2 infections, COVID-19-related hospitalizations and deaths are hypothesized to be dispro- portionately high among members of the Black, Asian, Mixed-race and Ethnic minorities (BAME) community. In this report, we analyse the characteristics and outcomes of COVID-19 patients from the BAME population in comparison with the White population. Our goal is to analyse the ethnic composition of the current COVID- 19 population in order to verify whether BAME patients are particularly vulnerable to COVID-19, and identify potential factors that could explain any increased susceptibility to the disease. Data In our analysis, we linked five different data sets in order to construct a comprehensive record of the different stages of COVID-19 patients’ health trajectories. The data sets involved in our analysis are described below. SGSS data. The first data set involved testing data ob- tained from the Second Generation Surveillance System (SGSS), covering the period to 16th April 2020. The data set contains 78,443 people with positive SARS-CoV-2 lab tests. This data set comprises patients at the first stage of their interaction with the NHS (diagnosis). CHESS data. The next stage is hospitalization and com- prises patients who are more severely ill. Data for COVID- 19 hospitalizations was obtained from the COVID-19 Hos- pitalization in England Surveillance System (CHESS) es- tablished by Public Health England (PHE). This data covered the period from February 8th to April 14th 2020 (7,714 hospital admissions, including 3,092 ICU admis- sions from 94 NHS hospital trusts across England). PDS data. We utilized the Personal Demographics Ser- vice (PDS) data from NHS Digital, which records 15,090 deaths due to COVID-19 up to April 20th, 2020. HES data. We used data from Hospital Episode Statis- tics (HES) in order to obtain information regarding each patient’s ethnicity. If a patient had multiple HES records with conflicting ethnicity, we chose the one with highest frequency. Primary care data. Finally, we used primary care pre- scription medicine data between July 2019 and January 2020 to extract information on each patient’s likely pre- existing medical conditions. Comorbidities were inferred on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa- tient. Using the data sets above, we constructed one compre- hensive data set for 72,358 COVID-19 patients, includ- ing information on whether each patient was hospitalized, whether they were admitted to the ICU, their comorbidi- ties, in addition to basic demographic information (age, sex and geographical region), and their outcome on April 20th, 2020. The data extraction process is shown in Figure 1. Methods We divided the COVID-19 population in England into 4 ethnic groups: White, Asian, Black and Other ethnic background. The definition of these ethnic groups were based on the standard HES ethnicity index. Descriptive statistics for age and the ethnic groups of interest were collected from the data sets above. In addition, a multi- variate mixed-effects Cox regression model was fit to ad- just for the effect of age and comorbidities on outcome, we also fit, with the fixed effects as the patient-level clinical predictors, and the random effects as the patient’s geo- graphical location. Results Of 78,443 patients with a positive COVID-19 test in the SGSS testing data, 72,358 (92%) had information on eth- nicity and formed the population of interest (Figure 1). By comparing the representation of patients from different ethnic groups at the different stages of COVID-19 disease (Figure 2), we found that BAME patients constitute a disproportionately large fraction of hospitalizations and 1

Upload: others

Post on 27-Jun-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Ethnic Composition and Outcomes of COVID-19 Patients

Ahmed M. Alaa1, Zhaozhi Qian2, Jem Rashbass3, Keith Gomes Pinto3, Jonathan Benger3, andMihaela van der Schaar2

1University of California, Los Angeles, CA 90095, USA2University of Cambridge Centre for Mathematical Sciences, Wilberforce Rd, Cambridge CB3

0WA, UK3NHS Digital

The rate of SARS-CoV-2 infections, COVID-19-related hospitalizations and deaths are hypothesized to be dispro-portionately high among members of the Black, Asian, Mixed-race and Ethnic minorities (BAME) community.In this report, we analyse the characteristics and outcomes of COVID-19 patients from the BAME populationin comparison with the White population. Our goal is to analyse the ethnic composition of the current COVID-19 population in order to verify whether BAME patients are particularly vulnerable to COVID-19, and identifypotential factors that could explain any increased susceptibility to the disease.

Data

In our analysis, we linked five different data sets in orderto construct a comprehensive record of the different stagesof COVID-19 patients’ health trajectories. The data setsinvolved in our analysis are described below.

SGSS data. The first data set involved testing data ob-tained from the Second Generation Surveillance System(SGSS), covering the period to 16th April 2020. The dataset contains 78,443 people with positive SARS-CoV-2 labtests. This data set comprises patients at the first stageof their interaction with the NHS (diagnosis).

CHESS data. The next stage is hospitalization and com-prises patients who are more severely ill. Data for COVID-19 hospitalizations was obtained from the COVID-19 Hos-pitalization in England Surveillance System (CHESS) es-tablished by Public Health England (PHE). This datacovered the period from February 8th to April 14th 2020(7,714 hospital admissions, including 3,092 ICU admis-sions from 94 NHS hospital trusts across England).

PDS data. We utilized the Personal Demographics Ser-vice (PDS) data from NHS Digital, which records 15,090deaths due to COVID-19 up to April 20th, 2020.

HES data. We used data from Hospital Episode Statis-tics (HES) in order to obtain information regarding eachpatient’s ethnicity. If a patient had multiple HES recordswith conflicting ethnicity, we chose the one with highestfrequency.

Primary care data. Finally, we used primary care pre-scription medicine data between July 2019 and January2020 to extract information on each patient’s likely pre-existing medical conditions. Comorbidities were inferred

on the basis of the British National Formulary (BNF)chapter code for all medications prescribed to each pa-tient.

Using the data sets above, we constructed one compre-hensive data set for 72,358 COVID-19 patients, includ-ing information on whether each patient was hospitalized,whether they were admitted to the ICU, their comorbidi-ties, in addition to basic demographic information (age,sex and geographical region), and their outcome on April20th, 2020. The data extraction process is shown in Figure1.

Methods

We divided the COVID-19 population in England into4 ethnic groups: White, Asian, Black and Other ethnicbackground. The definition of these ethnic groups werebased on the standard HES ethnicity index. Descriptivestatistics for age and the ethnic groups of interest werecollected from the data sets above. In addition, a multi-variate mixed-effects Cox regression model was fit to ad-just for the effect of age and comorbidities on outcome, wealso fit, with the fixed effects as the patient-level clinicalpredictors, and the random effects as the patient’s geo-graphical location.

Results

Of 78,443 patients with a positive COVID-19 test in theSGSS testing data, 72,358 (92%) had information on eth-nicity and formed the population of interest (Figure 1).By comparing the representation of patients from differentethnic groups at the different stages of COVID-19 disease(Figure 2), we found that BAME patients constitute adisproportionately large fraction of hospitalizations and

1

Page 2: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

ICU admissions, especially in younger age groups. Con-versely, in the group of patients aged 70 years and older,most of the patients were from the White population. Ta-ble 1 provides further summary statistics for each ethnicgroup. The proportion of patients who died in the Blackand Other ethnic groups exceeded the proportion of thesegroups in the general population as reported in the 2011census, whilst the proportion of deaths in the White eth-nic group was lower. However, direct comparisons withthe whole population in England in 2011 should be treatedwith caution because COVID-19 cases have occurred dis-proportionately in London, the West Midlands and otherurban areas where the population tends to be more eth-nically diverse, and the underlying population may havealtered to some extent since 2011 (see below).

Age disparities among ethnic groups. Figure 3 pro-vides a detailed break down of the age distribution ofCOVID-19 patients within each ethnic group. A signifi-cant difference in the age distributions of the White andBAME populations is apparent (Panel A). In particular,we found that the median age of diagnosed patients inthe Asian ethnic group was 51 years, significantly youngerthan the White patient population, for which the medianage was 69 years. In Panels C and B of Figure 3, wecompare the representation of each ethnic group withinspecific age groups, and compare these with the ethniccomposition of the baseline demographic based on the2011 census in England and Wales. Compared to thebaseline demographic, we observed an excess in the num-ber of patients from the Asian population in the age groupof less than 40 years old (15%) and 40-50 years old (19%)(Figure 3, Panel B). On the other hand, the elderly pop-ulation (more than 70 years old) was dominated by thewhite population (84%).

The marked difference in the age distribution between thewhite and BAME groups explains the lower rates of ICUadmission in the white population, and higher rates of ICUadmission in all other ethnic groups. The age gap betweenthe white and BAME populations may be explained by:(i) the difference in the underlying age distribution withineach ethnic group in the population, (ii) differences insocial deprivation which is consistently higher in BAMEpopulations (Figure 5), or (iii) differences in the age forthe first onset of chronic diseases and co-morbidities thatthemselves influence outcome (Figure 6).

Adjusting for baseline demographics. While BAMEpatients appear to be over-represented in the COVID-19diagnoses with respect to their representation in the over-all demographics of England (Figure 3, panels B and C),it is important to note that the COVID-19 population ismore concentrated in the more ethnically diverse regionsof England. That is, while the population of greater Lon-don comprises only around 14% of the overall populationof England, more than 24% of COVID-19 cases in ourdataset were associated with the greater London area. Bycomparing the rates of diagnosis in each ethnic group withtheir corresponding regional demographics (Figure 4), wefound that the diagnosis of COVID-19 generally reflectsthe underlying ethnic distribution in each region, howeverWhite and Asian populations are slightly less likely to

be diagnosed with COVID-19, compared to their regionalrepresentation, while Black and Mixed populations aremore likely to be diagnosed.

Prevalence of comorbidities. The vulnerability ofyounger patients in ethnic minorities to COVID-19 mayalso be explained by the prevalence of comorbidities inthese populations. As we can see in Figure 6, youngerBAME patients displayed higher prevalence cardiovascu-lar disease, endocrine disease and hypertension comparedto the white population.

Based on the observations above, the prevalence of comor-bidities at a younger age, combined with a younger demo-graphic, higher deprivation and the fact that ethnicallydiverse regions in England exhibited higher infection ratesmay explain the disproportionate rates of hospitalizationsand ICU admissions among young BAME patients. Inthe rest of this report, we examine the potential effectof ethnicity as a risk factor when adjusting for age andcomorbidities through a multi-variate regression model.

Ethnicity and risk elevation. Figure 7 shows the coef-ficients for all the clinical predictors under consideration inthe fitted multi-variate Cox model for mortality. We cansee that an Asian ethnic background significantly elevatesmortality risk even when adjusting for age and comorbidi-ties. This is explored further in Figure 8 in which thisanalysis is repeated, separating the Asian ethnic groupinto Indian, Pakistani and Bangladeshi in comparisonto other Asian ethnicity, and demonstrating that the In-dian, Pakistani and Bangladeshi ethnic group has a highermortality risk than other Asian individuals. To furtherillustrate the elevated risk within the Asian subgroup,Figure 9 shows the Kaplan-Meier estimates for the prob-ability of death plotted against the number of days sincediagnosis stratified by various age groups. We plot thesecurves for both patients in the overall population and pa-tients who have CHESS records (hospitalized). As we cansee, Asian patients display an elevated risk in older agegroups (more than 70 years old) for both the hospitalizedand non-hospitalized subgroups, and for the hospitalizedage group between 60 and 70 years old.

Discussion

There is a marked difference in the age distribution ofBAME and White patients diagnosed with COVID-19.While younger patients in the BAME population exhib-ited disproportionate diagnosis and ITU admission, thisapparent over-diagnosis may be explained by the widerspread of COVID-19 in ethnically diverse regions in Eng-land, the younger median age of the BAME populationcompared to the white population, higher rates of depri-vation in the BAME population and the higher prevalenceof other medical conditions within this population.

While the disproportionate diagnosis rate in BAME can beexplained through demographic factors, we still observedsignificantly higher rates of hospitalization within youngerBAME patients. Moreover, an Asian ethnic background,particularly Indian, Pakistani or Bangladeshi, was found

2

Page 3: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Population (2011) Diagnosis Hospitalization ICU Admission Deaths

White 48,209,395 (86%) 53,820 (74.6%) 5,149 (79.6%) 1,629 (68.7%) 11,286 (79.4.6%)Asian 4,213,531 (7.5%) 7,100 (9.8%) 581 (9.0%) 346 (14.6%) 989 (6.9%)Black 1,864,890 (3.3%) 4,778 (6.6%) 323 (5.0%) 155 (6.5%) 811 (5.7%)Other 1788096 (3.2%) 6,515 (9.0%) 414 (6.4%) 239 (10.0%) 1,127 (7.9%)

Table 1: Ethnic composition of patients at each stage of the COVID-19 trajectory.

to be a significant independent risk factor for mortalityeven after adjusting for age and co-morbidities. Of note,endocrine diseases (the vast majority of which will be di-abetes) are also a strong independent predictor of mortal-ity, and more prevalent in the Asian ethnic group. The

elevated risk within the Asian ethnic group may be at-tributed to other confounding clinical, social or geneticfactors, however we are unable to explore these further inthis analysis.

Respiratory Cardiovasc. Endocrine Malignant & Immunosup.

Asian 21.7% 64.9% 47.1% 1.7%Black 13.7% 69.8% 43.5% 3.8%OtherEth 15.7% 53.9% 30.9% 1.7%White 29.2% 71.2% 34.2% 3.3%

Table 2: Prevalence of comorbidities in different ethnic groups.

N Comorb. / Ethnicity 0 1 2 >=3

Asian 25% 26% 38% 12%Black 25% 27% 39% 9%OtherEth 40% 24% 30% 6%White 20% 35% 30% 15%

Table 3: Number of comorbidities in different ethnic groups.

3

Page 4: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

SGSS testing data 78,443 SARS-CoV-2

positive cases

HES data 72,358 COVID-19 cases

with ethnicity information

CHESS data 7,378 Hospitalized COVID-19 patients

6,085 patients with missing information

on ethnicity

78,443 COVID-19 diagnoses

72,358 COVID-19 cases with known ethnicity

72,358 COVID-19 cases with information on

hospitalization

PDS data 14,226

COVID-19-related deaths patients

72,213 COVID-19 cases with known outcomes as of April 20th, 2020

Figure 1: Data linkage and patient inclusion.

4

Page 5: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Ove

rall

po

pu

lati

on

A

ged

less

th

an 4

0 y

ears

A

ged

40

- 5

0 y

ears

Age

d 5

0 –

60

yea

rs

Age

d 6

0 –

70

yea

rs

Age

d m

ore

th

an 7

0 y

ears

Wh

ite

Asi

an

Bla

ck

Oth

er F

igu

re2:

Rep

rese

nta

tion

ofd

iffer

ent

eth

nic

gro

up

sfo

rva

riou

sage

ran

ges

acr

oss

diff

eren

tst

ages

of

the

CO

VID

-19

tra

ject

ory

.

5

Page 6: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Age

(ye

ars)

A

ge (

year

s)

Med

ian

:

51

yea

rs

Med

ian

:

69

yea

rs

Age

(ye

ars)

Med

ian

:

57

yea

rs

Asi

an

Bla

ck

Wh

ite

A

B C

Age

(ye

ars)

Med

ian

:

57

yea

rs

Oth

er

Wh

ite

A

sian

B

lack

O

the

r

Fig

ure

3:(A

)A

ged

istr

ibu

tion

for

CO

VID

-19

pat

ients

wit

hin

the

diff

eren

tet

hn

icgro

up

s.(B

)R

epre

senta

tion

of

the

diff

eren

tet

hn

icgro

up

sacr

oss

vari

ou

sage

ran

ges

wit

hin

the

CO

VID

-19

pop

ula

tion

.(C

)R

epre

senta

tion

ofth

ed

iffer

ent

eth

nic

gro

up

sacr

oss

vari

ou

sage

ran

ges

inth

ep

op

ula

tion

of

En

gla

nd

base

don

the

2011

cen

sus.

6

Page 7: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

80

4

0

0

20

1

0

0

20

1

0

0

5

2.5

0

Sou

th E

ast

Gre

ater

Lo

nd

on

No

rth

Wes

t

East

of

Engl

and

Wes

t o

f M

idla

nd

s

Sou

th W

est

York

shir

e an

d

the

Hu

mb

er

East

Mid

lan

ds

No

rth

Eas

t

% o

f in

div

idu

als

Wh

ite

Asi

an

Bla

ck

Oth

er

Pro

po

rtio

n in

re

gio

nal

dia

gno

ses

Pro

po

rtio

n in

re

gio

nal

po

pu

lati

on

Fig

ure

4:R

egio

nal

pro

por

tion

ofC

OV

ID-1

9d

iagn

oses

wit

hin

the

diff

eren

tet

hn

icgro

ups

com

pare

dto

the

regio

nal

dem

ogra

ph

ics

base

don

the

2011

cen

sus

for

En

gla

nd

.

7

Page 8: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

A

B

Ind

ex o

f m

ult

iple

dep

riva

tio

n (

IMD

)

Wh

ite

A

sian

B

lack

O

ther

Fig

ure

5:(A

)H

isto

gram

for

the

ind

exof

mu

ltip

led

epri

vati

on(I

MD

)am

on

gp

ati

ents

inva

riou

set

hnic

gro

up

s.(B

)M

edia

nIM

Din

vari

ou

sage

ran

ges

wit

hin

the

diff

eren

tet

hn

icgr

oup

s.

8

Page 9: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Wh

ite

A

sian

B

lack

O

ther

Car

dio

vasc

ula

r d

isea

se

Hyp

erte

nsi

on

Res

pir

ato

ry d

isea

se

End

ocr

ine

dis

ease

Fig

ure

6:P

reva

len

ceof

vari

ou

sco

morb

idit

ies

am

on

gd

iffer

ent

eth

nic

an

dage

gro

up

s.

9

Page 10: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Hazard ratio

Gastro-intestinal disease

Age

Cardiovascular disease

Sex: male

Diseases of the Nervous System

Endocrine disease

Ethnicity: Asian

Neoplasms

Respiratory disease

Hypertension

Ethnicity: Other

Ethnicity: Black

Deprivation index

Disease of the Genitourinary system

Figure 7: Coefficients of the Cox mixed-effects model for mortality.

10

Page 11: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Hazard ratio

Gastro-intestinal disease

Age

Cardiovascular disease

Sex: male

Diseases of the Nervous System

Endocrine disease

Neoplasms

Respiratory disease

Hypertension

Indian, Pakistani, Bangladeshi

Ethnicity: Black

Deprivation index Disease of the Genitourinary

system

Ethnicity: Other

Ethnicity: Other Asian ethnicity

Figure 8: Coefficients of the Cox mixed-effects model for mortality with separate modeling of the Indian subcontinentethnicity.

11

Page 12: Ethnic composition and outcomes of COVID-19 patients, 28 ......on the basis of the British National Formulary (BNF) chapter code for all medications prescribed to each pa-tient. Using

Age > 70,Hospitalized

Age > 70, Not Hospitalized

Age 60 - 70,Hospitalized

Age 50 - 60,Hospitalized

Age < 50, Hospitalized

Age 60 - 70, Not Hospitalized

Age 50 - 60, Not Hospitalized

Age < 50, Not Hospitalized

Mortality Risk for Hospitalized / Non-hospitalized patientsin Different Age Groups

Figure 9: Death probabilities over time.

12